Eugenia Girda, MD
Gynecologic Oncology · New Brunswick, NJNPI 1497032106
Payments from drug & device makers
Across 243 payments — averaging $17,301 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2M
- Merck$1.6M
- Astellas Pharma Global Development$175K
- Astrazeneca UK Limited$164K
- Genentech, Inc.$110K
- Exelixis Inc.$107K
- plus $58K from 7 others
Across 22 payments — averaging $323.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$6K
- F. Hoffmann-la Roche AG$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 162 | $1,993,029 |
| Merck | 39 | $1,597,995 |
| Astellas Pharma Global Development | 6 | $174,889 |
| Astrazeneca UK Limited | 4 | $163,671 |
| Genentech, Inc. | 12 | $109,835 |
| Exelixis Inc. | 9 | $106,769 |
| Blueprint Medicines Corporation | 1 | $30,347 |
| Adaptimmune LLC | 3 | $9,402 |
| Sumitomo Pharma America, Inc. | 1 | $7,913 |
| Sanofi US Services Inc. | 2 | $7,838 |
| Organon | 2 | $2,248 |
| Genentech USA, Inc. | 1 | $102 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
How this compares
$4,204,140 in reported general payments places this provider in the 95th percentile of 45 gynecologic oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New Brunswick
- Ruth StephensonNew Brunswick$18K
- Sara IsaniNew Brunswick$196
- Michael GoldbergNew Brunswick$187
- Sharyn LewinTeaneck$2.6M
- William BurkeParamus$2M
- Christina ChuCamden$1M
- Karim ElsahwiNeptune$904K
- David WarshalCamden$575K
- Akiva NovetskyNewark$486K
- Maria Schiavone ForlenzaTeaneck$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.